ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IMMX Immix Biopharma Inc

1.80
-0.02 (-1.10%)
22 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Immix Biopharma Inc NASDAQ:IMMX NASDAQ Common Stock
  Price Change % Change Share Price Shares Traded Last Trade
  -0.02 -1.10% 1.80 34,323 04:00:10
Bid Price Offer Price High Price Low Price Open Price
1.22 2.05 1.87 1.71 1.78
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations -15.43M -0.5608 -3.25 50.06M
Last Trade Time Trade Type Trade Size Trade Price Currency
20:05:08 1 1.80 USD

Immix Biopharma (IMMX) Latest News

Real-Time news about Immix Biopharma Inc (NASDAQ): 0 recent articles

Immix Biopharma Frequently Asked Questions (FAQ)

What is the current Immix Biopharma share price?
The current share price of Immix Biopharma is US$ 1.80
How many Immix Biopharma shares are in issue?
Immix Biopharma has 27,507,637 shares in issue
What is the market cap of Immix Biopharma?
The market capitalisation of Immix Biopharma is USD 50.06M
What is the 1 year trading range for Immix Biopharma share price?
Immix Biopharma has traded in the range of US$ 1.26 to US$ 3.3528 during the past year
What is the PE ratio of Immix Biopharma?
The price to earnings ratio of Immix Biopharma is -3.25
What is the reporting currency for Immix Biopharma?
Immix Biopharma reports financial results in USD
What is the latest annual profit for Immix Biopharma?
The latest annual profit of Immix Biopharma is USD -15.43M
What is the registered address of Immix Biopharma?
The registered address for Immix Biopharma is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
What is the Immix Biopharma website address?
The website address for Immix Biopharma is immixbio.com
Which industry sector does Immix Biopharma operate in?
Immix Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector